T/HBIQA 0005-2024 Active Group standards

T/HBIQA 0005-2024 Determination of Drug Concentrations of Five Rapamycin Target Inhibitors in Human Blood by High-Performance Liquid Chromatography-Tandem Mass Spectrometry (HPLI-MS/MS)

Publish Date: 2024-08-15 Implement Date: 2024-10-15 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/HBIQA 0005-2024

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Laboratory medicine

Publish Date: 2024-08-15

Implement Date: 2024-10-15

Scope

Main technical content: This document specifies the high-performance liquid chromatography-tandem mass spectrometry method for detecting the content of five rapamycin target protein inhibitor drugs in human blood. This document is applicable to the determination of the content of vitekset, AZD8055, GDC-0941, everolimus, and temsirolimus in human blood.